Combining hepatitis C treatment with HIV services for people who inject drugs in India
Integrating HCV services into HIV programs for PWID in India
This study is looking to help people in India who inject drugs by making it easier for them to get treatment for hepatitis C along with their HIV care, so they can have better health outcomes and support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11006630 on NIH RePORTER |
What this research studies
This research aims to improve health outcomes for people who inject drugs (PWID) in India by integrating hepatitis C (HCV) treatment into existing HIV services. The approach involves setting up integrated care centers that provide tailored support for HCV treatment alongside HIV prevention and care. By evaluating the effectiveness of different levels of treatment support, the research seeks to optimize treatment outcomes for individuals with HCV, whether they are solely infected or co-infected with HIV. The study will assess the impact of this integrated model on patient awareness, testing, and treatment success.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and are either infected with hepatitis C or co-infected with HIV.
Not a fit: Patients who do not inject drugs or those who are not infected with hepatitis C or HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the treatment and management of hepatitis C among PWID, leading to better health outcomes and reduced mortality.
How similar studies have performed: Previous research has shown success in integrating HCV services into HIV programs, indicating that this approach has potential for positive outcomes.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Mehta, Shruti H — Johns Hopkins University
- Study coordinator: Mehta, Shruti H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.